$248 Million is the total value of Blue Water Life Science Advisors, LP's 9 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GH | Buy | GUARDANT HEALTH INC | $52,670,000 | +56.5% | 978,445 | +17.3% | 21.26% | +16.3% |
| NTRA | Buy | NATERA INC | $48,403,000 | +46.9% | 1,104,581 | +18.8% | 19.54% | +9.2% |
| CYTEK BIOSCIENCES INC | $30,912,000 | +37.2% | 2,100,000 | 0.0% | 12.48% | +1.9% | ||
| TWST | New | TWIST BIOSCIENCE CORP | $28,368,000 | – | 805,000 | +100.0% | 11.45% | – |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $25,635,000 | +1.5% | 3,600,434 | +15.4% | 10.35% | -24.5% |
| AKYA | AKOYA BIOSCIENCES INC | $24,731,000 | -8.6% | 2,104,785 | 0.0% | 9.98% | -32.0% | |
| New | MAXCYTE INC | $20,963,000 | – | 3,225,000 | +100.0% | 8.46% | – | |
| TECH | BIO-TECHNE CORP | $13,206,000 | -18.1% | 46,500 | 0.0% | 5.33% | -39.1% | |
| SOMALOGIC INC | $2,877,000 | -35.8% | 992,086 | 0.0% | 1.16% | -52.3% | ||
| CDNA | Exit | CAREDX INC | $0 | – | -275,551 | -100.0% | -3.22% | – |
| BRKR | Exit | BRUKER CORP | $0 | – | -258,000 | -100.0% | -8.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NATERA INC | 12 | Q3 2023 | 33.3% |
| GUARDANT HEALTH INC | 12 | Q3 2023 | 21.3% |
| AKOYA BIOSCIENCES INC | 8 | Q3 2023 | 23.4% |
| ADAPTIVE BIOTECHNOLOGIES COR | 8 | Q3 2023 | 17.7% |
| CAREDX INC | 7 | Q2 2022 | 19.0% |
| THERMO FISHER SCIENTIFIC INC | 5 | Q4 2021 | 16.0% |
| MAXCYTE INC | 5 | Q3 2023 | 11.8% |
| BIO-TECHNE CORP | 5 | Q3 2022 | 8.8% |
| SOMALOGIC INC | 5 | Q3 2022 | 3.8% |
| CYTEK BIOSCIENCES INC | 4 | Q1 2023 | 12.5% |
View Blue Water Life Science Advisors, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-18 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Blue Water Life Science Advisors, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.